7 News & Press Releases found
Aresus Pharma GmbH News
-
New scientific paper published on the mechanism of action of Polyphenon E, a defined extract from green tea leaves, in preliminary stages of skin cancer
DERMAGO GmbH today announced the publication of an article by the research group of PD Dr. J. Eberle from Charité-Universitätsmedizin Berlin, Germany. The article entitled “Inhibition of Cell Proliferation and Cell Viability by ...
-
DERMAGO receives EUR 2 million from private investor network
In the financing round on Companisto, the pharmaceutical company DERMAGO GmbH received an investment commitment of just under 2 million euros within only a few weeks. More than 750 private investors participated in the pharmaceutical company, which ...
-
Aresus announces presentation of clincial data for the treatment of female sexual pain with sinecatechins ointment
Aresus Pharma GmbH, a subsidiary of DERMAGO GmbH, announced today that clinical results on the efficacy of 5-10% Topical Sinecatechins (synonyms: “Polyphenon® E“, ”defined extract from green tea leaves“) Ointment for ...
-
DERMAGO Group to expand its patent portfolio by acquiring the patents for the manufacture of the pharmaceutical agent Polyphenon® E from Mitsui Norin Co,Ltd.
DERMAGO Group (“DERMAGO”), announced today that it has acquired with immediate effect all patents regarding the manufacture of the pharmaceutical ingredient Polyphenon® E, a defined extract from green tea leaves, from the ...
-
Successful development and approval of Skinatan® 1 mg/g Emulsion – a new generic drug for the treatment of inflammations and allergic reactions
Skin Care Pharma GmbH, a company of Dermago Verwaltungs GmbH, announces that yet another milestone has been reached in the development and approval of Skinatan 1 mg/g Emulsion for cutaneous application with the active ingredient methylprednisolone ...
-
ePresentation of the results of the in-vitro study regarding the anti-proliferative and pro-apoptotic effects of Polyphenon E (Veregen) at the 31st German Skin Cancer Congress (Deutscher Hautkrebskongress) on 10 September 2021
Aresus Pharma GmbH, a company of DERMAGO Holding GmbH, announced today that the abstract “Inhibition of cell-proliferation and cell viability by Polyphenon E (Veregen) in cutaneous SCC cell lines” has been accepted as an e-poster ...
-
Aresus announces change in the management
Aresus Pharma GmbH, a subsidiary of DERMAGO Verwaltungs GmbH, has announced today that Dr. Francisco Harrison left his position as Managing Director for personal reasons. Dr. Harrison was in charge of Aresus‘ medical-scientific division. ...